Pharma Companies Are Outsourcing Less of Clinical Development Budget

Pharmaceutical Online reports that according to a study conducted by Cutting Edge Information, pharma companies across the industry are cutting back on outsourcing as a percentage of clinical development budgets. Compared to 2006, outsourcing as a percentage of the budget has reduced an average of 20% for every phase.

David Richardson, the lead author of the report mentions:

"Companies are now realizing that outsourcing does not necessarily make things easier, cheaper, or remove a burden from their plate. Research has appeared arguing against the cost-saving effects of outsourcing. Also, companies are being more frugal. Keeping things in-house grants easier oversight because of institutional proximity, ensuring efficient and competent work, instead of spending the same time managing a CRO."